A lot is riding on the October 31st event.
Neuralink is now ready to release more information about its brain implant research.
Elon Musk has disclosed that on October 31st, Neuralink would have a “show and tell” progress session. Neuralink has yet to begin human studies, and the Food and Drug Administration has not stated how close the company is to approval.
A comparable example would not be surprising.
Since the company’s inception six years ago, the majority of its co-founders have gone.
The presentation comes as reports circulate that Neuralink has offered to invest in its rival Synchron, which claims to have accomplished the first endovascular implant of a brain-computer interface in the United States.
Enable browser notifications to get Engadget breaking news updates. You may disable notifications in your settings menu at any time.